Functional visualization of the excretory system of adult Schistosoma mansoni by the fluorescent marker resorufin

Parasitology

Volumn 125, Issue 6, 2002, Pages 527-535

  Sato, H ^a,b   Kusel, J R ^a   Thornhill, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Drug efflux pump; Excretory system; P glycoprotein; Platyhelminth; Resorufin; Schistosoma mansoni

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; N (3,4 DIMETHOXYPHENETHYL) N METHYL 2 (2 NAPHTHYL) 1,3 DITHIANE 2 PROPYLAMINE; NIFEDIPINE; RESORUFIN; VERAPAMIL;

ARTICLE; CERCARIA; CONCENTRATION RESPONSE; DIFFUSION; EXCRETION; FLUORESCENCE; LABELING INDEX; NONHUMAN; PLATYHELMINTH; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMULUM; TECHNIQUE; ULTRASTRUCTURE;

INVERTEBRATA; MAMMALIA; PLATYHELMINTHES; SCHISTOSOMA; SCHISTOSOMA MANSONI; TREMATODA;

EID: 0036971105     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182002002536     Document Type: Article

References (52)

1. ALAOUI-JAMALI, M. A., SCHECTER, R. L., RUSTUM, Y. M., CENTURIONI, M. G., LEHNERT, S. & BATIST, G. (1993). In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933. Journal of Pharmacology and Experimental Therapeutics 264, 1299-1304.
2. AMBUDKAR, S. V., DEY, S., HRYCYNA, C. A., RAMACHANDRA, M., PASTAN, I. & GOTTESMAN, M. M. (1999). Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Review of Pharmacology and Toxicology 39, 361-398.
3. BENNETT, J. L., DAY, T., FENG-TAO, L., ISMAIL, M. & FARGHALY, A. (1997). The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel. Experimental Parasitology 87, 260-267.
4. BOGERS, J. J. P. M., NIBBELING, H. A. M., VAN MARCK, E. A. E. & DEELDER, A. M. (1995). Immunoelectron microscopical localization of a circulating antigen in the excretory system of Schistosoma mansoni; ultrastructural localization studies of the excretory system of S. mansoni. Parasitology Research 81, 375-381.
5. BORST, P., EVERS, R., KOOL, M. & WIJNHOLDS, J. (1999). The multidrug resistance protein family. Biochimica et Biophysica Acta 1461, 347-357.
6. BOSCH, I. B., WANG, Z.-X., TAO, L.-F. & SHOEMAKER, C. B. (1994). Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Molecular and Biochemical Parasitology 65, 351-356.
7. DALE, I. L., TUFFLEY, W., CALLAGHAN, R., HOLMES, J. A., MARTIN, K., LUSCOMBE, M., MISTRY, P., RYDER, H., STEWART, A. J., CHARLTON, P., TWENTYMAN, P. R. & BEVAN, P. (1998). Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. British Journal of Cancer 78, 885-892.
8. DE WATER, R., FRANSEN, J. A. M., SCHUT, D. W. O. A. & DEELDER, A. M. (1987). Three monoclonal antibodies with specific binding activity to the excretory system of Schistosoma mansoni: an immunoelectron microscopic study using the gold labeling technique. American Journal of Tropical Medicine and Hygiene 37, 345-352.
9. EBRAHIMZADEH, A. & KRAFT, M. (1971). Ultrastrukturelle Untersuchungen zur Anatomie der Cercarien von Schistosoma mansoni. II. Das Exkretionssystem. Zeitschrift für Parasitenkunde 36, 265-290.
10. ENDICOTT, J. A. & LING, V. (1989). The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry 58, 137-171.
11. EPAND, R. F., EPAND, R. M., GUPTA, R. S. & CRAGOE, E. J. JR. (1991). Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs. British Journal of Cancer 63, 247-251.
12. FALLON, P. G., TAO, L.-F., ISMAIL, M. M. & BENNETT, J. L. (1996). Schistosome resistance to praziquantel: Fact or artifact ? Parasitology Today 12, 316-320.
13. FINKEN, M., SOBEK, A., SYMMONS, P. & KUNZ, W. (1994). Characterization of the complete protein disulfide isomerase gene of Schistosoma mansoni and identification of the tissues of its expression. Molecular and Biochemical Parasitology 64, 135-144.
14. FINKEN-EIGEN, M. & KUNZ, W. (1997). Schistosoma mansoni: gene structure and localization of a homologue to cystein protease ER 60. Experimental Parasitology 86, 1-7.
15. FLENS, M. J., ZAMAN, G. J. R., VAN DER VALK, P., IZQUIERDO, M. A., SCHROEIJERS, A. B., SCHEFFER, G. L., DE HAAS, M., MEIJER, C. J. L. M. & SCHEPER, R. J. (1996). Tissue distribution of the multidrug resistance protein. American Journal of Pathology 148, 1237-1247.
16. FOJO, A. T., UEDA, K., SLAMON, D. J., POPLACK, D. G., GOTTESMAN, M. M. & PASTAN, I. (1987). Expression of a multidrug-resistance gene in human tumors and tissues. Proceedings of the National Academy of Sciences, USA 84, 265-269.
17. FORD, J. M. & HAIT, W. N. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Phamacological Reviews 42, 155-199.
18. 2+ exchanger. Biochimie 70, 1285-1290.
19. GARCIA, M. L., KING, V, F., SHEVELL, J. L., SLAUGHTER, R. S., SUAREZ-KURTZ, G., WINQUIST, R. J. & KACZOROWSKI, G. J. (1990). Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity. Journal of Biological Chemistry 265, 3763-3771.
20. HERZOG, C. E., TSOKOS, M., BATES, S. E. & FOJO, A. T. (1993). Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. Journal of Biological Chemistry 268, 2946-2952.
21. HIGGINS, C. F. (1992). ABC transporters: from microorganisms to man. Annual Review of Cell Biology 8, 67-113.
22. HUAI-YUN, H., SECREST, D. T., MARK, K. S., CARNEY, D., BRANDQUIST, C., ELMQUIST, W. F. & MILLER, D. W. (1998). Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochemical and Biophysical Research Communications 243, 816-820.
23. HUANG, Y.-J. & PRICHARD, R. K. (1999). Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Molecular and Biochemical Parasitology 102, 273-281.
24. KIM, H.-S., MIN, Y.-D. & CHOI, C.-H. (2001). Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid. Biochemical and Biophysical Research Communications 283, 64-71.
25. KLEIN, I., SARKADI, B. & VÅRADI, A. (1999). An inventory of the human ABC proteins. Biochimica et Biophysica Acta 1461, 237-262.
26. KLEYMAN, T. R. & CRAGOE, E. J. JR. (1998). Amiloride and its analogs as tools in the study of ion transport. Journal of Membrane Biology 105, 1-21.
27. KÖNIG, J., NIES, A. T., CUI, Y., LEIER, I. & KEPPLER, D. (1999). Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochimica et Biophysica Acta 1461, 377-394.
28. KÖSTER, B. & STRAND, M. (1994). Schistosoma mansoni: immunolocalization of two different fucose-containing carbohydrate epitopes. Parasitology 108, 433-446.
29. LEE, J. S., SCALA, S., MATSUMOTO, Y., DICKSTEIN, B., ROBEY, R., ZHAN, Z., ALTENBERG, G. & BATES, S. E. (1997). Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. Journal of Cellular Biochemistry 65, 513-526.
30. LIEBERMAN, D. M., REITHMEIER, R. A. F., LING, V., CHARUK, J. H. M., GOLDBERG, H. & SKORECKI, K. L. (1989). Identification of P-glycoprotein in renal brush border membranes. Biochemical and Biophysical Research Communications 162, 244-252.
31. MARTIN, C., BERRIDGE, G., MISTRY, P., HIGGINS, C., CHARLTON, P. & CALLAGHAN, R. (1999). The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. British Journal of Pharmacology 128, 403-411.
32. MAZZONI, A., TRAVE, F., CANTI, G. & FRANCO, P. (1989). Effect of the tiapamil analog Ro11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells. Anticancer Research 9, 367-372.
33. MECOZZI, B., ROSSI, A., LAZZARETTI, P., KADY, M., KAISER, S., VALLE, C., CIOLI, D. & KLINKERT, M.-Q. (2000). Molecular cloning of Schistosoma mansoni calcineurin subunits and immunolocalization to the excretory system. Molecular and Biochemical Parasitology 110, 333-343.
34. MISTRY, P., STEWART, A. J., DANGERFIELD, W., OKIJI, S., LIDDLE, C., BOOTLE, D., PLUMB, J. A., TEMPLETON, D. & CHARLTON, P. (2001). In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Research 61, 749-758.
35. MITCHELL, G. F. (1989). Glutathione S-transferases-potential components of anti-schistosome vaccines? Parasitology Today 5, 34-37.
36. REED, M. B., PANACCIO, M., STRUGNELL, R. A. & SPITHILL, T. W. (1998). Developmental expression of a Fasciola hepatica sequence homologous to ABC transporters. International Journal for Parasitology 28, 1375-1381.
37. RUPPEL, A., SHI, Y. E., WEI, D. X. & DIESFELD, H. J. (1987). Sera of Schistosoma japonicum-infected patients cross-react with diagnostic 31/32 kD proteins of S. mansoni. Clinical and Experimental Immunology 69, 291-298.
38. SANGSTER, N. C., BANNAN, S. C., WEISS, A. S., NULF, S. C., KLEIN, R. D. & GEARY, T. G. (1999). Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins and an association with avermectin/milbemycin resistance. Experimental Parasitology 91, 250-257.
39. SENFT, A. W., PHILPOTT, D. E. & PELOFSKY, A. H. (1961). Electron microscope observations of the integument, flame cells, and gut of Schistosoma mansoni. Journal of Parasitology 47, 217-229.
40. SKELLY, P. J. & SHOEMAKER, C. B. (2001). Schistosoma mansoni proteases Sm31 (cathepsin B) and Sm32 (legumain) are expressed in the cecum and protonephridia of cercariae. Journal of Parasitology 87, 1218-1221.
41. SMITHERS, S. R. & TERRY, R. J. (1965). The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adult worms. Parasitology 55, 695-700.
42. TANG, C.-M., PRESSER, F. & MORAD, M. (1988). Amiloride selectively blocks the low threshold (T) calcium channel. Science 240, 213-215.
43. r28K protective antigen of Schistosoma mansoni. EMBO Journal 7, 465-472.
44. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PASTAN, I. & WILLINGHAM, M. C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences, USA 84, 7735-7738.
45. THIMMAIAH, K. N., HORTON, J. K., QIAN, X. D., BECK, W. T., HOUGHTON, J. A. & HOUGHTON, P. J. (1990). Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines. Cancer Communications 2, 249-259.
46. TROTTEIN, F., KIENY, M. P., VERWAERDE, C., TORPIER, G., PIERCE, R. J., BALLOUL, J.-M., SCHMITT, D., LECOCQ, J.-P. & CAPRON, A. (1990). Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferase. Molecular and Biochemical Parasitology 41, 35-44.
47. TSURUO, T., IIDA, H., TSUKAGOSHI, S. & SAKURAI, Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Research 41, 1967-1972.
48. TSURUO, T., IIDA, H., TSUKAGOSHI, S. & SAKURAI, Y. (1982). Increased accumulation of vincristine and adriamycin in drug-resistant P3888 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Research 42, 4730-4733.
49. ULLMAN, B. (1995). Multidrug resistance and P-glycoproteins in parasitic protozoa. Journal of Bioenergetics and Biomembranes 27, 77-84.
50. UPCROFT, P. (1994). Multiple drug resistance in the pathogenic protozoa. Acta Tropica 56, 195-212.
51. WILSON, R. A. & WEBSTER, L. A. (1974). Protonephridia. Biological Reviews 49, 127-160.
52. XU, M., MOLENTO, M.. BLACKHALL, W., RIBEIRO, P., BEECH, R. & PRICHARD, R. (1998). Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Molecular and Biochemical Parasitology 91, 327-335.